Originally dba as Raindow Diganostics, Inc., Davinci Bio is structured around development of integrated imaging tools for single cell multiomics analysis and clinical diagnostics. Operations are anchored in a proprietary technology designated UltaFISH -- the next generation FISH having a significantly improved multiplex capacity and turnaround time than current FISH technology. What the firm has under development will be complementary with current single cell RNA sequencing and next generation sequencing technology for both single cell biology study and clinical diagnostics.
